2008 HIV Summit Presentations

E-mail Print

Opening Plenary Session

 

Welcome Addresses

Forum Welcome: Veronica Miller, PhD, Forum for Collaborative HIV Research
Co-Chairs Welcome: John Bartlett, MD, Johns Hopkins University; Kenneth Mayer, MD, Brown University
Official Welcome: Pierre Vigilance, MD, MPH, District of Columbia Department of Health

 

Updates

Update on HIV/AIDS epidemiology in the United States
Kevin Fenton, MD, PhD, FFPH, Centers for Disease Control and Prevention
Overview of Routine/Expanded HIV Testing in the US
Bernard Branson, MD, Centers for Disease Control and Prevention
Response to Update: Unmet Needs & Barriers
Donna Futterman, MD, Adolescent AIDS Program, Montefiore Medical Center
Jesse Milan, Jr., JD, Altarum Institute
HIV/AIDS in the District of Columbia: Part of the World Response
Shannon Hader, MD, MPH, District of Columbia Department of Health

 

Addressing the Epidemic: From Planning to Practice

Local Approaches to Fighting HIV/AIDS
Moderator: Monica S. Ruiz, PhD, MPH, Forum for Collaborative HIV Research
  • Shannon Hader, MD, MPH, District of Columbia Department of Health
  • Jane Cheeks, JD, MPH, Alabama Division of HIV/AIDS Prevention & Control
  • Daniela Torres, Alameda County Public Health Department, Office of AIDS Administration

Breakout Sessions

 

TRACK A - Routine/Expanded HIV Testing Models and Systems Development

Chairs: Judith Aberg, MD, New York University School of Medicine / Bellevue Hospital Center; Richard Rothman, MD, PhD, FACEP, Johns Hopkins University
 
Session 1: Update on New HIV Diagnostic Technologies
Moderator: Peter Leone, MD, North Carolina Health Department
Presenter: Bernard Branson, MD, Centers for Disease Control and Prevention
 
Session 2: Addressing Policy Changes: Lessons Learned
Moderator: Rob Janssen, MD, Gilead
Panelists:
Session 3: Implementation of Routine Testing: State, City and DOH initiatives
Moderator: Henry Masur, MD, Critical Care Medicine Department
Panelists:
Session 4: Implementation of Routine Testing: Traditional and Non-Traditional Clinical Setting
Moderator: Richard Rothman, MD, PhD, FACEP, Johns Hopkins University
Panelists:
Session 5: Implementation of Routine Testing: Non-clinical settings
Moderator: Judith Aberg, MD, New York University School of Medicine / Bellevue Hospital Center
Panelists:

TRACK B - Prevention Models in the Setting of Routine or Expanded HIV Testing

Chairs: Kenneth Mayer, MD, Brown University; Ronald Valdiserri, MD, MPH, US Department of Veterans Affairs
 
Session 1: Prevention for Positives: Linking Infected Persons to HIV Prevention Services
Moderator: Frank Oldham Jr., The National Association of People Living with AIDS
Substance Abuse and Risk Behavior among HIV-infected Persons: Implications for Inteventions
David Purcell, JD, PhD, Centers for Disease Control and Prevention
Interventions for Depression, Stress Management, and Engagement in Care for HIV-infected Persons
Steve Safren, PhD, MGH/Harvard and Fenway Community Health
Evaluating the HRSA SPNS Projects on Peer- and Clinician-delivered Interventions for HIV-positive Patients in Clinical Care
Janet Myers, PhD, MPH, University of California
 
Session 2: "You have 3 minutes": Reconfiguring HIV Prevention Messages and Interventions for the Routine Testing Context
Moderator: Ronald Valdiserri, MD, MPH, US Department of Veterans Affairs
Computer Tool for Routine Rapid HIV Counseling and Testing in Emergency Care Settings
Freya Spielberg, MD, MPH, Research Triangle Institute International/University of California San Francisco
Video-delivered Rapid HIV Pre-test Information to Streamline HIV Testing
Roland Merchant, MD, MPH, ScD, Warren Alpert Medical School at Brown University
Program BRIEF: A 32-month Analysis of a High Volume Rapid HIV Testing Multimedia Model
Yvette Calderon, MD, Jacobi Medical Center
 
Session 3: Addressing the Need for HIV Prevention Programs for Prioritized Communities
Moderator: Monica S. Ruiz, PhD, MPH, Forum for Collaborative HIV Research
HIV Prevention Needs of MSM of Color
Gregorio Millett, MPH, Centers for Disease Control and Prevention
HIV Prevention Needs of Women of Color
Sally Hodder, MD, University of Medicine and Dentistry of New Jersey
HIV Prevention Needs of Substance Using MSM
Ron Stall, PhD, MPH, University of Pittsburgh
HIV Prevention Needs of Correctional Populations
Barry Zack, MPH, The Bridging Group, LLC
 
Session 4: Examining Non-traditional Methods for Reducing the Rate of New Infections: Panel Discussions about the Impact of Serosorting and the Use of ART to Lower Community Viral Load
Moderator: Kenneth Mayer, MD, Brown University
The Role of Antiretroviral Therapy in Preventing Hiv Transmission
Myron Cohen, MD, University of North Carolina School of Medicine
HIV Diagnosis and STI Control: What is the Impact of Increasing Awareness of HIV Serostatus in the Context of Undiagnosed and Untreated STIs?
William McFarland, MD, PhD, San Francisco Department of Health
Community Perceptions about ART as Prevention, Serosorting, Strategic Positioning, and Disclosure and How these Affect Risk Behavior
Richard Wolitski, PhD, Centers for Disease Control and Prevention
 
Session 5: Social Marketing for HIV Testing and Prevention
Moderator: W. Douglas Evans, PhD, George Washington University School of Public Health and Health Services
So You Think You're Safe? Increasing Awareness for HIV Risk Among Women at a Family Planning Clinic
Carmen Zorilla, MD, CHAC/University of Puerto Rico School of Medicine
Operation Sweet Tooth: Effective use of Social Marketing Campaigns in Non-traditional Social Settings
Terence McPhaul, MA, NCSC, National AIDS Education & Services for Minorities
From Palmcards to PSAs and Beyond: The Role of Media in Making HIV Screening a New Community Norm
Abby Ginzberg, Ginzberg Productions

 

TRACK C - Outcomes and Impact Evaluation of HIV Testing Activities

Chairs: Michael Horberg, MD, MAS, Kaiser Permanente; Roger Pomerantz, MD, FACP, Tibotec
 
Session 1: What We Know and What We Don't Know about the Effectiveness of implementing Routine HIV Testing
Moderator: Michael Horberg, MD, MAS, Kaiser Permanente
Rates of HIV Testing in the US Since the 2006 Recommendations: Metrics for Different Sites and Venues
Denise Duran, MPH, Centers for Disease Control and Prevention
HRSA Perspective
Faye Malitz, MS, Health Resources and Services Administration
Private Sector Perspective
Michael Horberg, MD, MAS, Kaiser Permanente
 
Session 2: Routine Testing and Access to Care: Individual and Systems-level Metrics
Moderator: Daniel Seekins, MD, Bristol-Myers Squibb
Measuring Impact of Routine Testing on Disease Stage at Time of Entry into Care
Elena Losina, PhD, Brigham and Women's Hospital
The Potential for Routine Testing to Reduce the Racial/Ethnic Disparities Associated with Late Entry into Care
Victoria Cargill, MD, MSCE, Office of AIDS Research/National Institutes of Health
 
Session 3: Panel Discussion of Implementation Metrics and Costs
Moderator: Deborah Cotton, MD, MPH, The Clinton Foundation
Cost of Finding One Newly Diagnosed HIV Case in New York City
Benjamin Tsoi, MD, MPH, New York City Department of Health and Mental Hygiene
Using Capacity Building Models to Estimate Organizational Costs of HIV Care Within the United States Department of Veterans' Affairs
Henry Anaya, PhD, MS, US Department of Veteran's Affairs
Cost Effectiveness of Routine Opt-out Rapid HIV Screening in the Emergency Department: Results from an Ongoing Prospective Clinical Trial
Jason Haukoos, MD, MSc, Denver Health Medical Center
 
Session 4: Who are the remaining 25%: Identifying Those with Undiagnosed HIV Infection
Moderator: Carl Dieffenbach, PhD, National Institutes of Health
Looking behind the barrier: what we know about undiagnosed, HIV-infected populations
Elizabeth DiNenno, PhD, Centers for Disease Control and Prevention
Reaching the undiagnosed in the South
Cheryl Modica, PhD, National Association of Community Health Centers, Inc.
Identifying the undiagnosed in South Carolina
Wayne Duffus, MD, PhD, South Carolina Department of Health and Environmental Control
 
Session 5: Unintended and Unanticipated Social Outcomes Associated with HIV Testing
Moderator: Kevin Fenton, MD, PhD, FFPH, Centers for Disease Control and Prevention
How do we know what we know? Measuring the Unintended Consequences of HIV Testing - program perspective
Israel Nieves-Rivera, Urban Coalition of HIV Prevention Services
How Do We Know What We Know? Measuring the Unintended Consequences of HIV Testing - community perspective
Kali Lindsey, National Association of People with AIDS
HIV Diagnosis in Pediatric and Adolescent Populations
Natella Rakhmanina, MD, FAAP, AAHIVS, Children's National Medical Center

 

TRACK D - Access to Care as a Part of Routine/Expanded Testing

Chairs: John Bartlett, MD, Johns Hopkins University; Michael Saag, MD, University of Alabama
 
Session 1: Financing Testing, Care, and Retention in Care
Moderator: Christine Lubinski, HIV Medicine Association/Infectious Diseases Society of America
Overview of Public Sector Financing
John Bartlett, MD, Johns Hopkins University
Overview of Private Sector Financing
David Mosen, MD, MPH, Kaiser Permanente Center
Hidden Costs of Care
Michael Saag, MD, University of Alabama
 
Session 2: Late entry into care; retention in care: current findings and implications
Moderator: John Bartlett, MD, Johns Hopkins University
Who is Showing Up Late into Care?
John Bartlett, MD, Johns Hopkins University
Innovative Programs for Retention in Care?
Sally Hodder, MD, University of Medicine and Dentistry of New Jersey
Barriers to Retention in Care
Michael Mugavero, MD, University of Alabama at Birmingham
 
Session 3: Workforce Needs and Challenges in Delivery of HIV Care
Moderator: Michael Saag, MD, University of Alabama at Birmingham
HIVMA-FCHR Survey on Workforce Needs
Andrea Weddle, MSW, HIV Medicine Association
Treatment Effectiveness: How Many People are Failing Treatment? What are the Projections?
Veronica Miller, PhD, Forum for Collaborative HIV Research
Optimal Provider to Patient Ratios
Michael Saag, MD, University of Alabama at Birmingham
 
Session 4: Linking Testing to Care; Retention in Care in various settings
Moderator: Joseph Bick, MD, California Department of Corrections and Rehabilitation
Linkages to Care for the District of Columbia's Most Vulnerable Populations
Michael Kharfen, District of Columbia Department of Health, HIV/AIDS Administration
Challenges Associated with Linking HIV-infected Inmates with Post-release Care and Services
Josiah Rich, MD, MPH, Brown University
Outreach Activities by the National Medical Association
Wilbert Jordan, MD, Oasis Clinic

 

Closing Plenary Session

 

Testing, Serostatus Knowledge, and Implications for Prevention

Gary Marks, PhD, Centers of Disease Control and Prevention

 

Who Pays for HIV testing?

Moderator: Monica Sweeney, MD, MPH, FACP, New York City Department of Health and Mental Hygiene
Speakers:
  • Marsha Martin, DSW, Get Screened Oakland
  • Carl Schmid, MBA, The AIDS Institute

Panel Discussion: When to Start HIV Treatment?

Moderator: John Bartlett, MD, Johns Hopkins University
Presenter:
  • Fred Gordin, MD, Veterans Affairs Medical Center
  • Veronica Miller, PhD, Forum for Collaborative HIV Research
  • Frank Oldham Jr., The National Association of People Living with AIDS
  • Discussants: Rochelle Walensky, MD, MPH, Harvard University
  • Myron Cohen, MD, University of North Carolina School of Medicine

Panel Discussion: Linking testing to care- Where do We Go from Here?

Moderator: John Bartlett, MD, Johns Hopkins University
Panelists:
  • Kevin Fenton, MD, PhD, FFPH, Centers for Disease Control and Prevention
  • Deborah Parham Hopson, PhD, RN, Health Resources and Services Administration, HIV/AIDS Bureau
  • Carl Dieffenbach, PhD, National Institutes of Health

Panel Discussion: The HIV Care Workforce- Where do We Go from Here?

Moderator: Michael Saag, MD, University of Alabama
Panelists:
  • Arlene Bardeguez, MD, MPH, FACOG, HIV Medicine Association
  • Laura Cheever, MD, ScM, Health Resources and Services Administration, HIV/AIDS Bureau
  • Judith Feinberg, MD, American Academy of HIV Medicine

Proposal for a National Plan of Action

Moderator: Veronica Miller, PhD, Forum for Collaborative HIV Research
Speakers:
  • Christine Lubinski, HIV Medicine Association/IDSA
  • David Ernesto Munar, AIDS Foundation of Chicago

Closing Comments

Forum: Veronica Miller, PhD, Forum for Collaborative HIV Research
Co-Chairs: John Bartlett, MD, Johns Hopkins University
Kenneth Mayer, MD, Brown University